Integra LifeSciences Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Tech stocks bolster Wall Street as Nvidia quells AI growth concerns
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil rises by over $1 as White House says no US-Iran talks happening
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
- First Financial to acquire Hickory Point Bank in $111.3M deal
Integra LifeSciences (IART) Misses Q1 EPS by 16c
May 7, 2020 6:41 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.48, $0.16 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $354.3 million versus the consensus estimate of $363.24 million.
2020 Full-Year Outlook
Given the existing uncertainty related to COVID-19, the Companys guidance for the full-year 2020, issued... More
